Site US892 is a clinical research site located in Grand Rapids, Michigan, United States 49546.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Site US892 has participated in 1 clinical trials.
Therapeutic areas: Prostatic Neoplasms.
Sponsors: Astellas Pharma Inc.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site US892 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site US892 has 1 clinical trials on record. Their work covers Prostatic Neoplasms.
Site US892 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.